Ann Gils (A Gils)

Publication Activity (10 Years)

Years Active: 2017-2019
Publications (10 Years): 4

Top Topics

Ulcerative Colitis

Decision Making

Top Venues

Alimentary pharmacology & therapeutics

Clinical pharmacology and therapeutics

The British journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Erwin Dreesen, Ann Gils
Letter: overcoming secondary loss of response to infliximab-it is not the drug, it is how you use it! Authors' reply. Alimentary pharmacology & therapeutics 48 (9) (2019)
Nathalie Van den Berghe, E De Keyser, Rani Soenen, L Meuleman, S Lanssens, Ann Gils, Jo Lydie Wilfried Lambert
Clinical response correlates with 4-week postinjection ustekinumab concentrations in patients with moderate-to-severe psoriasis. The British journal of dermatology 182 (2) (2019)
Nathalie Van den Berghe, Ann Gils, Debby Thomas
Achieving Mucosal Healing in Inflammatory Bowel Diseases: Which Drug Concentrations Need to Be Targeted? Clinical pharmacology and therapeutics 106 (5) (2019)
E Dreesen, T Van Stappen, V Ballet, M Peeters, G Compernolle, S Tops, K Van Steen, G Van Assche, Marc Ferrante, S Vermeire, Ann Gils
Anti-infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response. Alimentary pharmacology & therapeutics 47 (3) (2017)